Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples